These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22802580)
41. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent. Erben RG Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418 [TBL] [Abstract][Full Text] [Related]
42. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042 [TBL] [Abstract][Full Text] [Related]
43. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease. Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658 [TBL] [Abstract][Full Text] [Related]
44. Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Goldstein SL; Devarajan P Adv Chronic Kidney Dis; 2008 Jul; 15(3):278-83. PubMed ID: 18565478 [TBL] [Abstract][Full Text] [Related]
45. The role of FGF23 in CKD--with or without Klotho. Komaba H; Fukagawa M Nat Rev Nephrol; 2012 Jun; 8(8):484-90. PubMed ID: 22714041 [TBL] [Abstract][Full Text] [Related]
46. Pathophysiological implications of fibroblast growth factor-23 and Klotho and their potential role as clinical biomarkers. Donate-Correa J; Muros de Fuentes M; Mora-Fernández C; Navarro-González JF Clin Chem; 2014 Jul; 60(7):933-40. PubMed ID: 23757358 [TBL] [Abstract][Full Text] [Related]
47. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human. Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610 [TBL] [Abstract][Full Text] [Related]
48. Klotho deficiency aggravates sepsis-related multiple organ dysfunction. Jorge LB; Coelho FO; Sanches TR; Malheiros DMAC; Ezaquiel de Souza L; Dos Santos F; de Sá Lima L; Scavone C; Irigoyen M; Kuro-O M; Andrade L Am J Physiol Renal Physiol; 2019 Mar; 316(3):F438-F448. PubMed ID: 30516423 [TBL] [Abstract][Full Text] [Related]
49. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease]. Lacroix JS; Urena-Torres P Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356 [TBL] [Abstract][Full Text] [Related]
50. The protective effect of klotho against contrast-associated acute kidney injury via the antioxidative effect. Oh HJ; Oh H; Nam BY; You JS; Ryu DR; Kang SW; Chung YE Am J Physiol Renal Physiol; 2019 Oct; 317(4):F881-F889. PubMed ID: 31411071 [TBL] [Abstract][Full Text] [Related]
51. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications? Kuro-O M Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324 [TBL] [Abstract][Full Text] [Related]
52. Validity of Klotho, CYR61 and YKL-40 as ideal predictive biomarkers for acute kidney injury: review study. Mosa O; Skitek M; Jerin A Sao Paulo Med J; 2017; 135(1):57-65. PubMed ID: 27759760 [TBL] [Abstract][Full Text] [Related]
53. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086 [TBL] [Abstract][Full Text] [Related]
54. Role of Klotho in aging, phosphate metabolism, and CKD. John GB; Cheng CY; Kuro-o M Am J Kidney Dis; 2011 Jul; 58(1):127-34. PubMed ID: 21496980 [TBL] [Abstract][Full Text] [Related]
55. Does AKI truly lead to CKD? Rifkin DE; Coca SG; Kalantar-Zadeh K J Am Soc Nephrol; 2012 Jun; 23(6):979-84. PubMed ID: 22460531 [TBL] [Abstract][Full Text] [Related]
56. New insights into the FGF23-Klotho axis. Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378 [TBL] [Abstract][Full Text] [Related]
57. [Progress in clinical nephrology 2008: CKD, and AKI as well]. Watanabe T Nihon Jinzo Gakkai Shi; 2009; 51(1):13-8. PubMed ID: 19238902 [No Abstract] [Full Text] [Related]
58. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury. Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384 [TBL] [Abstract][Full Text] [Related]
60. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection]. Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]